| Size & multiples | |||
| Market Cap | $20.1M | Enterprise Value | — |
| P/E (TTM) | — | PEG (trailing) | — |
| P/S | 2.65× | P/FCF | — |
| EV/EBITDA | — | EV/EBIT | — |
| EV/Sales | — | EV/FCF | — |
| FCF Yield | −113.14% | Buyback Yield | — |
| Owner Earnings (TTM) | -$15.4M | Owner Earnings Yield | −76.90% |
| Shareholder Yield | — | ||
| Cost of capital & EVAmethodology → | |||
| Beta (5y monthly) | — | Risk-free (assumed) | 4.00% |
| Equity risk premium (assumed) | 5.00% | Cost of Equity | — |
| After-tax Cost of Debt | — | WACC | — |
| ROIC | — | EVA Spread (ROIC−WACC) | — |
| EVA | — | ||
FCF sits 47% below owner earnings — spending above maintenance (growth capex) or absorbing working capital, so FCF understates the steady-state cash the business throws off.
Flows TTM (last 4 quarters) · EPS TTM — · revenue TTM $7.6M · FCF TTM -$22.7M
Output of a disclosed model whose assumptions may be wrong — research information, not investment advice. See the Disclaimer.
Compared against all 1054 Health Care names we cover — one sector-wide pool, so the median skews toward smaller (often unprofitable) companies. Try the Size band for a cap-matched read.
| Metric | This (FY) | Peer median | IQR (25–75) | %ile |
|---|---|---|---|---|
| FCF Yield | -122.3% | -7.9% | -35.6%–1.4% | 11 ↓weak |
| Operating Margin | -374.8% | -34.5% | -552.0%–8.0% | 28 ↓weak |
